Nuclear Morphology of Breast Cells in Ductal Lavage
Morphometry of Breast Cells in Ductal Lavage
2 other identifiers
observational
57
1 country
1
Brief Summary
Breast nipple aspirate fluids (NAF) are useful for non-invasive monitoring of the breast. NAF has been shown to exhibit large inter-individual differences in lipid peroxidation. Unfortunately, the yield of epithelial cells in NAF is low. More recently, breast ductal lavage has been approved for clinical use. Nuclear morphologic features of breast biopsies have been shown previously to have prognostic value for breast cancer risk. In women without cancer, there may be subtle changes in the breast epithelial cells that can only be defined with computer-assisted measurements. The subjects selected for this study will be 98 women with biopsy-confirmed proliferative breast disease. These women are at slightly increased breast cancer risk, and exhibit higher mean levels of cholesterol and cholesterol oxides in NAF than women with non-proliferative histology in the breast. Levels of 8-isoprostane, cholesterol, fatty acids, fat-soluble micronutrients and 2,6-cyclolycopene-4,5-diol will be quantified in breast NAF that is obtained before breast lavage. These measures were chosen based on their potential relationship to dietary intakes and to oxidative stress, which is relevant to the application of these methods to dietary prevention studies.The investigators will characterize the morphology of breast epithelial cells from lavage using quantitative image cytometry to capture nuclear and cellular area, diameter, roundness, perimeter, and nuclear:cytoplasmic area ratio. Correlations will be evaluated between the measured morphologic features and each analyte in the NAF. The impact of various clinical, demographic and dietary factors on cellular morphology will also be explored. This study will help establish the feasibility of using these measures as endpoints in dietary intervention studies and will generate hypotheses that should be tested in larger studies. Such measures also should be applicable to molecular epidemiological investigations that seek to examine the impact of certain gene polymorphisms and environmental exposures on biomarkers of cancer risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2004
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
November 28, 2005
CompletedFirst Posted
Study publicly available on registry
November 29, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2007
CompletedDecember 20, 2012
November 1, 2008
3 years
November 28, 2005
December 19, 2012
Conditions
Keywords
Interventions
breast ductal lavage and nipple aspiration done once
Eligibility Criteria
women with a previous biopsy of proliferative breast disease
You may qualify if:
- Age 18 and older
- A diagnosis of proliferative breast disease
- At least 1 month post biopsy
- At least 3 months post any therapy such as tamoxifen
- Good general health
- Sign Consent Form.
You may not qualify if:
- Pregnant or lactating (lactation must have stopped at least 3 months prior)
- Taking coumadin
- Any diseases including cardiovascular, high blood pressure and diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- Wayne State Universitycollaborator
Study Sites (1)
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
Related Publications (1)
Djuric Z, Edwards A, Madan S, Darga L, Ren J, Blake C, Koletsky M, Heilbrun LK. Obesity is associated with atypia in breast ductal lavage of women with proliferative breast disease. Cancer Epidemiol. 2009 Oct;33(3-4):242-8. doi: 10.1016/j.canep.2009.07.003. Epub 2009 Jul 28.
PMID: 19683484RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zora Djuric, PhD
University of Michigan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Professor
Study Record Dates
First Submitted
November 28, 2005
First Posted
November 29, 2005
Study Start
June 1, 2004
Primary Completion
June 1, 2007
Study Completion
June 1, 2007
Last Updated
December 20, 2012
Record last verified: 2008-11